Experts have promised a game-changing set of new vaccines for a variety of diseases, including cancer.
A major pharmaceutical company believes that vaccines for cancer, cardiovascular and autoimmune diseases, and other conditions will be available by 2030.
Studies into these vaccinations are also showing “tremendous promise,” with some researchers claiming that 15 years of progress has been “unspooled” in 12 to 18 months as a result of the Covid jab’s success.
Moderna’s chief medical officer, Dr Paul Burton, believes the company will be able to offer such treatments for “all sorts of disease areas” in as little as five years.
The firm, which created a leading coronavirus vaccine, is developing cancer vaccines that target different tumour types.
Burton said: “We will have that vaccine and it will be highly effective, and it will save many hundreds of thousands, if not millions of lives. I think we will be able to offer personalised cancer vaccines against multiple different tumour types to people around the world.”
He also stated that multiple respiratory infections could be covered by a single injection, protecting vulnerable people from Covid, flu, and respiratory syncytial virus (RSV), and that mRNA therapies could be available for rare diseases that currently have no drugs. mRNA-based therapies work by instructing cells on how to produce a protein that activates the body’s immune response to disease.
Burton said :“I think we will have mRNA-based therapies for rare diseases that were previously undruggable, and I think that 10 years from now, we will be approaching a world where you truly can identify the genetic cause of a disease and, with relative simplicity, go and edit that out and repair it using mRNA-based technology.”